Early tolerance to hemodynamic effects of high dose transdermal nitroglycerin in responders with severe chronic heart failure
Authors:
- Arie RothARArie Roth
- Daniel KulickDKDaniel Kulick
- Lindalee FreidenbergerLFLindalee Freidenberger
- Robert HongRHRobert Hong
- Shahbudin H. RahimtoolaSRShahbudin H. Rahimtoola
- Uri ElkayamUEUri Elkayam
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure.Circulation, 1985
- The brief saga of transdermal nitroglycerin discs: Paradise lost?The American Journal of Cardiology, 1984
- Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failureThe American Journal of Cardiology, 1984
- Acute hemodynamic effect of oral nifedipine in severe chronic congestive heart failureThe American Journal of Cardiology, 1983
- Tolerance to isosorbide dinitrate: rate of development and reversal.Circulation, 1983
- Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.Circulation, 1983
- Hemodynamic Characterization of Tolerance to Long-Term Hydralazine Therapy in Severe Chronic Heart FailureNew England Journal of Medicine, 1982
- Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate.Circulation, 1980
- Rebound Hemodynamic Events after the Abrupt Withdrawal of Nitroprusside in Patients with Severe Chronic Heart FailureNew England Journal of Medicine, 1979
- Effects of long-term oral administration of isosorbide dinitrate on the antianginal response to nitroglycerinThe American Journal of Cardiology, 1978